Thiol-mediated Uptake of a Cysteine-containing Nanobody for Anti-Cancer Drug Delivery
F. Goerdeler, E. E. Reuber, J. Luehle, S. Leichnitz, A. Freitag, R. Nedielkov, H. M. Moeller, P. H. Seeberger, O. Moscovitz
This paper describes a nanobody that binds and internalizes into B cell lymphoma via thiol interactions, enabling drug delivery and diagnostic applications.
bioRxiv · Jul 12, 2022 · PreprintCancer Biology